home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> mail archive   |   Search register for news alert (free)  
  Bergen (ioi): CALL: various - March 96  
   

archive of HUM-MOLGEN mails

 
 

[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index]

To: Multiple recipients of list HUM-MOLGEN <HUM-MOLGEN@NIC.SURFNET.NL>
Subject: CALL: various - March 96
From: "Bergen (ioi)" <A.A.Bergen@AMC.UVA.NL>
Date: Tue, 9 Apr 1996 14:17:10 +0200

Note from the editor:

New CALLs!
With a single E-mail you can now reach over ***3500*** colleagues from
***60*** countries world-wide, with an interest in genetics and molecular
biology, for free!

The CALL section is open for CALLs for collaborations, info requests
(only for info which cannot obtained easily elsewhere),
offers of assistance, grant deadline CALLs, CALLs for papers, etc.
Occaisionally, replies will be posted at the end of this file.

Please send high quality messages only, including your full name,
institute and E-mail adress. Please respond to a CALL by private E-mail
only, unless your reply is of interest to the entire HUM-MOLGEN community.
The editor may refuse low-quality messages without further notice!

Good CALLs!

Arthur Bergen
(owner HUM-MOLGEN)
******************************************************************************

>From bgold@ITSA.UCSF.EDUTue
From: Bert Gold <bgold@ITSA.UCSF.EDU>

This message was originally submitted  by bgold@ITSA.UCSF.EDU to the HUM-MOLGEN
list at NIC.SURFNET.NL.

Netters,

You may be interested in reading an article written for general audiences
entitled "Trends in Human Genetics: Vital Data" on pages 100-105 of the
March 1996 Scientific American by staff writer Tim Beardsley.

Not only does it contain excellent photographs of Francis (Collins)
sitting on his motorcycle [sorry Francis...] and Bill Haseltine
looking dapper in his best combed hair and new suit [sorry Bill],
but it also contains a worthwhile overview of the ELSI controversies
currently surrounding the genome project.

As most of you know I have rather strong opinions on most of these
issues, so I will spare you my repeating my feelings here;
nevertheless, I would say that this article by Beardsley is
a must read for anyone who wishes to understand human genetics today,
and as it is to be practiced into the future.


Bert Gold, Ph.D.
University of California, San Francisco
School of Medicine
Program in Medical Genetics

PS - Bill and Francis, I think you both look very fine in the article
     and hope that you find my remarks (at least a little) jocular.
      - Bert
*****************************************************************************
>From ZJVA47A@prodigy.comTue Apr  9 13:33:26 1996
Date: Wed, 06 Mar 1996 00:16:23 -0500 (EST)
From: DIREC PAUL G TOMEY <ZJVA47A@prodigy.com>

This message was originally submitted  by ZJVA47A@PRODIGY.COM to the HMG-MOLGEN
list at NIC.SURFNET.NL.

My 4 yr old son demonstrates the ability to roll the tongue into the
familiar "u" shape--of this I am certain.  I am equally certain that
neither his mom nor myself are "rollers".  I understand this is
impossible.

His mom has cleft pallet, and received several surgical operations
for this condition in early childhood.

Is the cleft pallet, or surgery, or neither responsible for an
inability to express this otherwise dominant trait?

Or should I doubt my paternity?

I would appreciate a response at your earliest convenience.

Thanks so much.

Paul

************************************************************************
>From WPCMJO@CARDIFF.AC.UKTue Apr  9 13:34:00 1996
Date: Fri, 08 Mar 1996 11:42:02 +0000 (GMT)
From: MIKE OWEN <WPCMJO@CARDIFF.AC.UK>

This message was originally submitted by WPCMJO@CARDIFF.AC.UK to the HUM-MOLGEN
list at NIC.SURFNET.NL.

We are interested in receiving DNA from individuals with
hyperekplexia and other startle syndromes for mutation analysis of
GLRA1. Sporadic as well as familial cases are of interest since we
have found reccessive as well as dominant cases due to mutations in
GLRA1.
Mike Owen
Depts. of Psychological Medicine and Medical Genetics,
University of Wales College of Medicine,
Heath Park,
Cardiff CF4 4XN,
UK.
Tel. 44 1222 743248
Fax. 44 1222 747839
email wpcmjo@cardiff.ac.uk
*****************************************************************************
>From chipper@gdb.orgTue Apr  9 13:34:26 1996
Date: Fri, 08 Mar 1996 09:50:42 -0500 (EST)
From: Mike Chipperfield <chipper@gdb.org>
To: bergen@AMC.UVA.NL
Subject: New contact information

Hello,

Effective Friday, March 1, I have resigned as a member of the Genome Data Base
staff. I have taken a position as database consultant at Sybase Corporation,
effective March 4.

Please direct all future inquiries regarding GDB data submission to:

                data@gdb.org

For those who wish to reach me personally, my new contact information is as
follows:

                Phone: (301) 896-1102
                FAX:   (301) 896-1602
                Email: Michael.Chipperfield@sybase.com

Sincerely,

Michael A. Chipperfield
*************************************************************************

From: Bernd Stein <bstein@SIGNALPHARM.COM>
Reply to: Human Molecular Genetics Editors <ED-MOLGEN@nic.SURFnet.nl>

This  message  was  originally   submitted  by  bstein@SIGNALPHARM.COM  to  the
HUM-MOLGEN list at  NIC.SURFNET.NL.

I am looking for information on the 1996 World Congress on Osteoporosis,
Amsterdam, 18-23 May.

I was unable to get information by sending a request to their Fax number.

___________________________________________________________________
Dr. Bernd Stein                 |  Phone 619-558-7500
Signal Pharmaceuticals          |  FAX   619-558-7513
5555 Oberlin Drive              |  bstein@signalpharm.com
San Diego, CA 92121             |

***********************************************************************
>
>You very kindly posted an announcment of a satellite meeting for QA
>at the upcoming European Society for Human Genetics in London. Could
>you please include the following note for the attention of relevant
>subscribers to help me present some data on various national QA
>systems?

>Quality Assurance Schemes for Clincal Molecular Genetics:
>
>I've been asked to try and review various National Clinical Molecular
>Genetics QC schemes in operation for the EQA meeting of 10th April.
>So far
>I have a limited amount of data on Australian and US schemes.  I
>wondered if
>you were aware of any schemes running in your own country and if you
>could
>tell me anything about them,  especially regarding the following
>points:
>
>1. Who organises the scheme?
>2. Who participates in the scheme?
>3. Is the scheme recognised by Healthcare and/or Government?
>4. What tests are evaluated?
>5. Do you look at data interpretation and genotyping?
>6. How are the results scored?
>7. Is there a strategy for dealing with persistant poor performers?
>8. What types of samples are distributed?
>9. How is the scheme funded?
>10. Are their any features you would like to include in future
>schemes not
>already in place?
>11. Have you encountered any particular problems in administration of
>the
>scheme?
>
>thanks,
>GR Taylor PhD MRCPath
>Regional Clinical Molecular Genetics Lab,
>St James's University Hospital, Leeds LS9 7TF
>phone 113 283 7084  fax 113 267 7090
>email gtaylor@hgmp.mrc.ac.uk
>http://dspace.dial.pipex.com/town/square/ai80/
***************************************************************************

>From ccmoema@EMBRATEL.NET.BRTue Apr  9 13:35:44 1996
Date: Sun, 10 Mar 1996 04:52:30 +0100
From: Audrey Ogawa <ccmoema@EMBRATEL.NET.BR>

ccmoema@embratel.net.br (Audrey Ogawa) sent the following comments:

------------------------------------------------------------
Hi, I am a student of medicine and I am very  interested in doing a research
in the Genetics area. I am also thinking about making a fly lab with
drosophila. If you can give me any help in one of these subjects, or
know where I can find out more information, please, email me at
ccmoema@embratel.net.br
Any help you can give is a big help. Thanks for your attention.
------------------------------------------------------------
Server protocol: HTTP/1.0
Remote host: drjo014A101.embratel.net.br
Remote IP address: 200.255.254.101
************************************************************************
>From johnhands@EASYNET.CO.UKTue Apr  9 13:36:16 1996
Date: Mon, 11 Mar 1996 17:39:49 +0000
From: John Hands <johnhands@EASYNET.CO.UK>

This  message  was  originally  submitted  by  johnhands@EASYNET.CO.UK  to  the
HUM-MOLGEN list at  NIC.SURFNET.NL.

I am researching a book and would be most grateful to know of any
conferences during 1996 in the USA at which developments in two areas of
human molecular genetics may be announced or discussed:

1. Anti-aging treatments

2. Cancer treatments

With thanks

John Hands
Author, UK
*************************************************************************
>From leslieb@HELIX.NIH.GOVTue Apr  9 13:36:54 1996
Date: Mon, 11 Mar 1996 15:47:29 -0500
From: Leslie Biesecker <leslieb@HELIX.NIH.GOV>

This  message   was  originally  submitted  by   leslieb@HELIX.NIH.GOV  to  the
HUM-MOLGEN list at  NIC.SURFNET.NL.

I would be grateful for the Email address of Dr. J-P Fryns of Leuven, Belgium.

Leslie Biesecker, MD
National Institutes of Health
National Center for Human Genome Research
Building 49 Room 4A80
Bethesda, MD  20892-4470
Telephone: 301-402-2041
Fax: 301-402-2170
****************************************************************************
>From jptalm@DWX.COMTue Apr  9 13:37:20 1996
Date: Mon, 11 Mar 1996 23:11:32 +0100
From: Amy McKeen <jptalm@DWX.COM>
To: Multiple recipients of list ED-MOLGEN <ED-MOLGEN@nic.SURFnet.nl>
Subject: Call:information
Resent-Date: Mon, 11 Mar 1996 23:11:32 +0100
Resent-From: owner-ed-molgen@HEARN.NIC.SURFNET.NL
Resent-To: A.A.Bergen@AMC.UVA.NL

jptalm@dwx.com (Amy McKeen) sent the following comments:

------------------------------------------------------------
My name is Amy McKeen.  I am a junior biology major at Drake University
in Des Moines, Iowa.  I am doing a term paper on the debate over the
genetic basis for homosexuality.  If anyone could provide me with
information or further resources on this topic, it would be
greatly appreciated.

Amy McKeen
E-mail: jptalm@dwx.com
------------------------------------------------------------
Server protocol: HTTP/1.0
Remote host: sl-dwx-1-12.dsm.dwx.net
Remote IP address: 198.207.231.28
****************************************************************************
>From KJKhacker1@AOL.COMTue Apr  9 13:37:51 1996
Date: Tue, 12 Mar 1996 22:44:45 -0500
From: KJKhacker1@AOL.COM

This message was  originally submitted by KJKhacker1@AOL.COM  to the HUM-MOLGEN
list at NIC.SURFNET.NL.

can you tell me in as much detail as you can, how eye color is inherited.
******************************************************************************

>From MARIS@EMAIL.CHOP.EDUTue Apr  9 13:38:20 1996
Date: Thu, 14 Mar 1996 08:19:59 -0500
From: "John Maris M.D." <MARIS@EMAIL.CHOP.EDU>

This message was originally submitted by MARIS@EMAIL.CHOP.EDU to the HUM-MOLGEN
list at NIC.SURFNET.NL.

We are interested in the molecular genetics of familial neuroblastoma and
have an IRB approved protocol for specimen procurement and linkage analysis.

We would appreciate being notified of any patients/families that meet any of the following criteria and whom might be interested in providing a blood sample (archival tumor specimens useful also):

1.  Proband with one or more first degree relative with neuroblastoma, ganglioneuroblastoma or ganglioneuroma.

2.  Proband affected with and/or with one or more first degree relative with Hirschsprung disease or hypoventilation syndrome.

3.  Neuroblastoma patients with any other co-morbid condition (congenital malformations, mental retardation, etc.).

We will be happy to provide additional information.  Furthermore, we will send copies of consent and specimen procurement forms at your request.

Thank you.

John M. Maris, MD
The Children's Hospital of Philadelphia
fax:  215-590-3770
voice: 215 590-5242
email: maris@email.chop.edu
***************************************************************************
>From hsiao@MAIL.PMF.ORG.TWTue Apr  9 13:41:00 1996
Date: Mon, 18 Mar 1996 07:30:59 +0100
From: "Kwang-Jen Hsiao, Ph.D." <hsiao@MAIL.PMF.ORG.TW>

hsiao@mail.pmf.org.tw (Kwang-Jen Hsiao, Ph.D.) sent the following comments:

------------------------------------------------------------
We are looking for the following references, which are not available
locally in Taiwan.  Anyone can send us a copy will be highly appreciated.

1) PAH Gene Mutation Analysis Consortium Newsletter (October, 1994).

2) PAH Gene Mutation Analysis Consortium Newsletter (December,
1993).

Thank you in advance!

---------------------------------------------------------------------
Kwang-Jen Hsiao, Ph.D.
Professor, Institute of Genetics    Investigator
National Yang-Ming University       Clin. Biochem. Res. Laboratory
Peitou P.O. Box 2-207               Dept. of Medical Res. & Education
Taipei, Taiwan 11216                Veterans General Hospital-Taipei

Tel: 886-2-875-7401         E-mail: hsiao@mail.pmf.org.tw
Fax: 886-2-873-3517                 hsiao@ms1.hinet.net
---------------------------------------------------------------------

------------------------------------------------------------
Server protocol: HTTP/1.0
Remote host:
Remote IP address: 192.72.15.20
***************************************************************************
>From R.Clarke@UNSW.EDU.AUTue Apr  9 13:41:46 1996
Date: Mon, 18 Mar 1996 23:30:41 +0100
From: Raymond Clarke <R.Clarke@UNSW.EDU.AU>

R.Clarke@unsw.edu.au (Raymond Clarke) sent the following comments:

------------------------------------------------------------
We want to characterise squamous cell carcinomas. We need advice on markers that
may help us get a handle on a set of very aggressive tumours that we have
been studying. We would appreciate an experienced collaborator for this study.
------------------------------------------------------------
Server protocol: HTTP/1.0
Remote host:
Remote IP address: 129.94.50.56
**********************************************************************
>From BrownEB_at_USNORALL@CCIP.PERKIN-ELMER.COMTue Apr  9 13:42:53 1996
Date: Wed, 20 Mar 1996 10:16:57 -0500 (EST)

This message was originally submitted by BrownEB_at_USNORALL@CCIP.PERKIN-ELMER.
COM to the HUM-MOLGEN list at NIC.SURFNET.NL.

     Where could I find out how many times a particular paper has been
     referenced?  Please let me know.

     e-mail address:  BrownEB@perkin-elmer.com
*****************************************************************************
>From pmorris@MEDICINE.ADELAIDE.EDU.AUTue
Date: Thu, 21 Mar 1996 17:05:50 +0900
From: Phillip Morris <pmorris@MEDICINE.ADELAIDE.EDU.AU>

This message  was originally  submitted by  pmorris@MEDICINE.ADELAIDE.EDU.AU to
the HUM-MOLGEN  list at NIC.SURFNET.NL.

        I am interested in viewpoints on the usage and meaning of the terms
"polymorphism" and "mutation".  There are numerous definitions in many texts
but it may be reasonable to summarize them in their most basic form as:

polymorphism - the coexistence of two or more variants in a population
mutation - a variant in the population that differs from "wild type"

        The definitions of polymorphism that I have come across often, but not
always, involve some minimum value of the frequency of the least abundant
allele.  However, this allele frequency value varies from definition to
definition, between >0.1 and >1x10-9 (the approximate mutation frequency of
any given base in the genome). Mutation definitions also imply that the
allele frequency of mutations must be less than 50% since it is not wild type?

        I find it difficult to distinguish between the two terms and I would
appreciate hearing ANY thoughts on the matter.  I am particularly interested
in WELL referenced definitions or anecdotes about the derivation or
evolution of these terms.

        I would also like comments on the idea that, in general human genetics
usage, polymorphisms are considered to be harmless while mutations are
presumed to be deleterious.

        All comments are welcomed.

Phillip Morris

__________________________________________

C. Phillip Morris
Department of Chemical Pathology
Women's and Children's Hospital
North Adelaide, SA 5006  Australia
Tel.   61 8 204-7330
Fax.  61 8 204-7100
E-mail   pmorris@medicine.adelaide.edu.au
_________________________________________
***************************************************************************

>From 108LAS@COSMOS.WITS.AC.ZATue Apr  9 13:45:33 1996
Date: Mon, 25 Mar 1996 10:59:27 +0100
From: Lara Stein <108LAS@COSMOS.WITS.AC.ZA>
Reply to: Human Molecular Genetics Editors <ED-MOLGEN@nic.SURFnet.nl>
To: Multiple recipients of list ED-MOLGEN <ED-MOLGEN@nic.SURFnet.nl>
Subject: "mad-cow disease"
Resent-Date: Mon, 25 Mar 1996 10:59:27 +0100
Resent-From: owner-ed-molgen@HEARN.NIC.SURFNET.NL
Resent-To: A.A.Bergen@AMC.UVA.NL

I am interested to know the origin of the scare in Britain about
"mad cow disease"/scrapie. Has an article been published in the
scientific literature suggesting that humans can be affected by
eating beef from infected cattle?

Lara Stein
University of Witwatersrand
South Africa
108las@cosmos.wits.ac.za
********************************************************************

>From mimipeg@UCLINK2.BERKELEY.EDUTue Apr  9 13:51:44 1996
Date: Mon, 25 Mar 1996 18:00:40 -0800
From: Margaret Conrad <mimipeg@UCLINK2.BERKELEY.EDU>

This message  was originally  submitted by mimipeg@UCLINK2.BERKELEY.EDU  to the
HUM-MOLGEN list at  NIC.SURFNET.NL.

From: Peggy Conrad/  Genetic Counseling Student/ UC Berkeley

Subject:  Acetylation polymorphism/ debrisoquine polymorphism

I would appreciate hearing from anyone who may be aware of a recent
comprehensive review article on the above subject. I am particularly
interested in the clinical implications for the different phenotypes, with
regard to drug  response and spontaneous other disorders.  Please respond
via my email.  Thank You.

***************************************************************************
>From l.nasir@UDCF.GLA.AC.UKTue Apr 9 13:47:33 1996 Date: Wed, 27 Mar 1996
12:22:43 +0000 (GMT) From: lubna nasir <l.nasir@UDCF.GLA.AC.UK> Reply to:
Human Molecular Genetics Editors <ED-MOLGEN@nic.SURFnet.nl> To: Multiple
recipients of list ED-MOLGEN <ED-MOLGEN@nic.SURFnet.nl> Subject: CALL
Resent-Date: Wed, 27 Mar 1996 12:22:43 +0000 (GMT) Resent-From:
owner-ed-molgen@HEARN.NIC.SURFNET.NL Resent-To: A.A.Bergen@AMC.UVA.NL

This  message  was  originally   submitted  by  l.nasir@UDCF.GLA.AC.UK

1) We are looking for researchers who may have a p53 riboprobe that we may
use against a couple of Northern Blotts.

2) We are also interested in contacting anyone who may have a feline cDNA
library.


Thanks


Lubna Nasir



Dr. Lubna Nasir/S. Duthie
Dept Veterinary Clinical Studies
University of Glasgow Veterinary School
Bearsden Road
Glasgow
G61 1QH
Scotland UK
Tel: +44-0141-330-6918/5730
Fax: +44-0141-330-6996
Dr. Lubna Nasir
Dept Veterinary Clinical Studies
University of Glasgow Veterinary School
Bearsden Road
Glasgow
G61 1QH
Scotland UK
Tel: +44-0141-330-6918/5730
Fax: +44-0141-330-6996
*************************************************************************
>From hamilton@EXPRESS.CATue Apr  9 13:47:54 1996
Date: Sun, 31 Mar 1996 21:34:42 +0200

hamilton@express.ca (HAMILTON) sent the following comments:

------------------------------------------------------------
LOOKING FOR ELIZABETH LIEW'S E MAIL ADRESS.
SHE STUDIES GENETICS AT UBC.I WOULD LIKE TO CONTACT HER.
      :)

                                                IAN HAMILTON
------------------------------------------------------------
Server protocol: HTTP/1.0
Remote host: ppp3.express.ca
Remote IP address: 206.12.15.34


   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Mail converted by MHonArc 2.4.4
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.